These Numbers Show Favorable Signs for Unicycive Therapeutics Inc (UNCY)

Unicycive Therapeutics Inc (NASDAQ: UNCY) is -57.93% lower on its value in year-to-date trading and has touched a low of $0.20 and a high of $1.82 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The UNCY stock was last observed hovering at around $0.38 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.37, the stock is -1.48% and -19.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.71 million and changing -3.44% at the moment leaves the stock -57.92% off its SMA200. UNCY registered -52.54% loss for a year compared to 6-month loss of -76.90%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -20.13% gain in the last 1 month and extending the period to 3 months gives it a -61.41%, and is -2.64% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.28% over the week and 16.14% over the month.

Unicycive Therapeutics Inc (UNCY) has around 14 employees, a market worth around $34.44M and $0.00M in sales. Distance from 52-week low is 80.69% and -79.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-95.94%).

The EPS is expected to grow by 45.18% this year.

Unicycive Therapeutics Inc (UNCY) Top Institutional Holders

27.0 institutions hold shares in Unicycive Therapeutics Inc (UNCY), with institutional investors hold 32.42% of the company’s shares. The shares outstanding are 94.36M, and float is at 83.54M with Short Float at 1.60%. Institutions hold 30.24% of the Float.

The top institutional shareholder in the company is VIVO CAPITAL, LLC with over 3.47 million shares valued at $1.74 million. The investor’s holdings represent 9.9395% of the UNCY Shares outstanding. As of 2024-06-30, the second largest holder is LOGOS GLOBAL MANAGEMENT LP with 3.47 million shares valued at $1.74 million to account for 9.9389 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 2.82 million shares representing 8.0783% and valued at over $1.41 million, while RA CAPITAL MANAGEMENT, L.P. holds 7.5394 of the shares totaling 2.63 million with a market value of $1.32 million.